NN 106 CytoC

The Department of Neurology is pleased to announce that UPMC CancerCenter has been selected to participate in the NN 106 CytoC study for patients with newly diagnosed primary glioblastoma multiforme. Jan Drappatz, MD is the Site PI and Melinda Vargas-Jaffe, RN, CCRC is the Site Study Coordinator. This study is currently enrolling participants. Click here to read more.